Abivertinib

abivertinib · Sorrento Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abivertinib, covering 2023-01-18 to 2023-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 [Phase 2]

See pricing